Mediastinal lymph nodes in patients with non-small cell lung cancer: Preliminary experience with diffusion-weighted MR imaging

Journal of Thoracic Imaging

Volumn 23, Issue 3, 2008, Pages 157-161

  Hasegawa, Ichiro ^a   Boiselle, Phillip M ^b   Kuwabara, Katsuyuki ^a   Sawafuji, Makoto ^a   Sugiura, Hitoshi ^a  

^a KAWASAKI MUNICIPAL HOSPITAL   (Japan)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Diffusion weighted images; Lung neoplasms; Lymphatic system; Magnetic resonance

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; MEDIASTINUM LYMPH NODE; NUCLEAR MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MEDIASTINUM; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS;

EID: 58149108928     PISSN: 08835993     EISSN: None     Source Type: Journal    
DOI: 10.1097/RTI.0b013e318166d2f5     Document Type: Article

References (40)

1. Takahara T, Imai Y, Yamashita T, et al. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med. 2004;22:275-282.
2. Wang J, Takashima S, Takayama F, et al. Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging. Radiology. 2001;220:621-630.
3. Taouli B, Vilgrain V, Dumont E, et al. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology. 2003;226:71-78.
4. Ichikawa T, Erturk SM, Motosugi U, et al. High-b value diffusion-weighted MRI for detecting pancreatic adenocarcinoma: preliminary results. AJR Am J Roentgenol. 2007;188:409-414.
5. Guo Y, Cai YQ, Cai ZL, et al. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging. 2002;16:172-178.
6. Kinoshita T, Yashiro N, Ihara N, et al. Diffusion-weighted half-Fourier single-shot turbo spin echo imaging in breast tumors: differentiation of invasive ductal carcinoma from fibroadenoma. J Comput Assist Tomogr. 2002;26:1042-1046.
7. Issa B. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging. J Magn Reson Imaging. 2002;16:196-200.
8. Ichikawa T, Erturk SM, Motosugi U, et al. High-B-value diffusion-weighted MRI in colorectal cancer. AJR Am J Roentgenol. 2006; 187:181-184.
9. Matoba M, Tonami H, Kondou T, et al. Lung carcinoma: diffusion-weighted MR imaging - preliminary evaluation with apparent diffusion coefficient. Radiology. 2007;243:570-577.
10. Bueno R, Richards WG, Swanson SJ, et al. Nodal stage after induction therapy for stage III A lung cancer determines patient survival. Ann Thorac Surg. 2000;70:1826-1831.
11. Martini N, Heelan R, Westcott J, et al. Comparative merits of conventional, computed tomographic, and magnetic resonance imaging in assessing mediastinal involvement in surgically confirmed lung carcinoma. J Thorac Cardiovasc Surg. 1985;90:639-648.
12. Musset D, Grenier P, Carette MF, et al. Primary lung cancer staging: prospective comparative study of MR imaging with CT. Radiology. 1986;160:607-611.
13. Laurent F, Drouillard J, Dorcier F, et al. Bronchogenic carcinoma staging: CT versus MR imaging-assessment with surgery. Eur J Cardiothorac Surg. 1988;2:31-36.
14. Webb WR, Gatsonis C, Zerhouni EA, et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology. 1991;178: 705-713.
15. Glazer GM, Orringer MB, Gross BH, et al. The mediastinum in non-small cell lung cancer: CT-surgical correlation. AJR Am J Roentgenol. 1984;142:1101-1105.
16. McLoud TC, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology. 1992;182:319-323.
17. Magnani P, Carretta A, Rizzo G, et al. FDG/PET and spiral CT image fusion for mediastinal lymph node assessment of non-small cell lung cancer patients. J Cardiovasc Surg (Torino). 1999;40: 741-748.
18. Seely JM, Mayo JR, Miller RR, et al. T1 lung cancer: prevalence of mediastinal lymph node metastases and diagnostic accuracy of CT. Radiology. 1993;186:129-132.
19. Hammoud ZT, Anderson RC, Meyers BF, et al. The current role of mediastinoscopy in the evaluation of thoracic disease. J Thorac Cardiovasc Surg. 1999;118:894-899.
20. Gupta NC, Tamim WJ, Graeber GG, et al. Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging. Chest. 2001;120: 521-527.
21. Wahl RL, Quint LE, Greenough RL, et al. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology. 1994;191: 371-377.
22. Steinert HC, Hauser M, Allemann F, et al. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology. 1997;202:441-446.
23. Weng E, Tran L, Rege S, et al. Accuracy and clinical impact of mediastinal lymph node staging with FDG-PET imaging in potentially resectable lung cancer. Am J Clin Oncol. 2000;23:47-52.
24. Roberts PF, Follette DM, von Haag D, et al. Factors associated with false-positive staging of lung cancer by positron emission tomography. Ann Thorac Surg. 2000;70:1154-1159; discussion 1159-1160.
25. Liewald F, Grosse S, Storck M, et al. How useful is positron emission tomography for lymphnode staging in non-small-cell lung cancer? Thorac Cardiovasc Surg. 2000;48:93-96.
26. Farrell MA, McAdams HP, Herndon JE, et al. Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease. Radiology. 2000;215:886-890.
27. Guhlmann A, Storck M, Kotzerke J, et al. Lymph node staging in non-small cell lung cancer: evaluation by (18F) FDG positron emission tomography (PET). Thorax. 1997;52:438-441.
28. Shim SS, Lee KS, Kim BT, et al. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology. 2005;236:1011-1019.
29. Takenaka D, Ohno Y, Hatabu H, et al. Differentiation of metastatic versus non-metastatic mediastinal lymph nodes in patients with non-small cell lung cancer using respiratory-triggered short inversion time inversion recovery (STIR) turbo spin-echo MR imaging. Eur J Radiol. 2002;44:216-224.
30. Ohno Y, Hatabu H, Takenaka D, et al. Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative and qualitative assessment with STIR turbo spin-echo MR imaging. Radiology. 2004;231:872-879.
31. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol. 2007;188:1622-1635.
32. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest. 1997;111:1718-1723.
33. Gamsu G, Webb WR, Sheldon P, et al. Nuclear magnetic resonance imaging of the thorax. Radiology. 1983;147:473-180.
34. Cohen AM, Creviston S, LiPuma JP, et al. NMR evaluation of hilar and mediastinal lymphadenopathy. Radiology. 1983;148:739-742.
35. Georgian D, Rice TW, Mehta AC, et al. Intrathoracic lymph node evaluation by CT and MRI with histopathologic correlation in non-small cell bronchogenic carcinoma. Clin Imaging. 1990;14:35-40.
36. Lyng H, Haraldseth O, Rofstad EK. Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn Reson Med. 2000; 43:828-836.
37. Nicholson AG, Graham AN, Pezzella F, et al. Does the use of immunohistochemistry to identify micrometastases provide useful information in the staging of node-negative non-small cell lung carcinoma? Lung Cancer. 1997;18:231-240.
38. Passlick B, Izbicki JR, Kubuschok B, et al. Detection of disseminated lung cancer cells in lymph nodes: impact on staging and prognosis. Ann Thorac Surg. 1996;61:177-183.
39. Salerno CT, Frizelle S, Niehans GA, et al. Detection of occult micrometastases in non-small cell lung carcinoma by reverse transcriptase- polymerase chain reaction. Chest. 1998;113: 1526-1532.
40. Dobashi K, Sugio K, Osaki T, et al. Micrometastatic P53-positive cells in the lymph nodes of non-small cell lung cancer: prognostic significance. J Thorac Cardiovasc Surg. 1997;114:339-346.